Philip A. Sharp, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 15,000 shares at $149.00 ($2.2M) on 2018-03-13, disclosed to the SEC on 2018-03-14.
Open-market sale of $2.2M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALNY | SELL | 2017-02-03 | $2.0M | — | Filing → |
| ALNY | SELL | 2017-01-27 | $569K | — | Filing → |
| ALNY | SELL | 2017-01-20 | $804K | — | Filing → |